Jan 7 () - The United Arab Emirates' drug regulator has ​recalled certain Nestle infant formula ‌products after the company recalled specific batches ‌over a potential toxin risk, the state news agency (WAM) reported on Wednesday. The Emirates Drug Establishment said no ⁠illness or ‌adverse events linked to the affected batches have been ‍reported or confirmed, WAM added.

(Reuters) -Researchers monitoring the brain activity of a patient with a severe binge-eating problem reported that Eli Lilly's GLP-1 weight-loss drug appeared to temporarily suppress food-craving ​signals in the "reward center" of the brain. These are the first direct measurements of brain activity ‌in a person receiving tirzepatide, sold as Mounjaro for diabetes and Zepbound for weight loss, shedding light on the treatment's impact on so-called ‌food noise.

By 2030, more than 70 million Americans will have osteoporosis or low bone mass.